The unplanned readmission rate is a measure of quality for medical institutions handling various acute healthcare needs. It is a measure that the government uses in Medicare reimbursements to the hospitals, and gives an indication of how the quality of care in the medical institution is (Wilbur, et al., 2016). While surveying the readmission rates for women having gynecological complications, Wilbur et al., (2016) observed that the readmission is costly for the patients as they often warranted more complex medical interventions. The same perspective is shared by Mark et al., (2013), whose studies led to the conclusion that the costs of readmission are too high for both the patients and the hospitals to sustain. Therefore, a reduction in the
